|
US5997873A
(en)
|
1994-01-13 |
1999-12-07 |
Mount Sinai School Of Medicine Of The City University Of New York |
Method of preparation of heat shock protein 70-peptide complexes
|
|
US6719974B1
(en)
*
|
1995-08-18 |
2004-04-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
HUP9802819A2
(hu)
*
|
1995-08-18 |
1999-03-29 |
Sloan-Kettering Institute For Cancer Research |
Hősokkfehérje-alapú oltóanyagok és immunterápiák
|
|
US6761892B1
(en)
*
|
1995-08-18 |
2004-07-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US6773707B1
(en)
*
|
1995-08-18 |
2004-08-10 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US5837251A
(en)
*
|
1995-09-13 |
1998-11-17 |
Fordham University |
Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
|
|
US5985270A
(en)
*
|
1995-09-13 |
1999-11-16 |
Fordham University |
Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
|
|
IN183280B
(enExample)
|
1996-09-20 |
1999-10-30 |
Univ New Mexico |
|
|
US7157089B1
(en)
|
1996-11-26 |
2007-01-02 |
Stressgen Biotechnologies Corporation |
Immune responses using compositions containing stress proteins
|
|
US6017540A
(en)
|
1997-02-07 |
2000-01-25 |
Fordham University |
Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
|
|
US6709672B2
(en)
|
1997-03-05 |
2004-03-23 |
Biotech Tools S.A. |
Pharmaceutical or food composition for treating pathologies associated with graft rejection or an allergic or autoimmune reaction
|
|
BE1011033A6
(fr)
*
|
1997-03-05 |
1999-04-06 |
Univ Bruxelles |
Composition pharmaceutique et/ou alimentaire pour le traitement de pathologies liees a un rejet de greffe, une reaction allergique ou auto-immune ou du cancer.
|
|
CA2298840A1
(en)
*
|
1997-08-05 |
1999-02-18 |
Stressgen Biotechnologies Corporation |
Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins
|
|
JP2002501722A
(ja)
*
|
1997-10-31 |
2002-01-22 |
スローン−ケターリング インスティチュート フォー キャンサー リサーチ |
熱ショックタンパク質結合性コンジュゲートペプチド
|
|
US5948646A
(en)
|
1997-12-11 |
1999-09-07 |
Fordham University |
Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
|
|
EP2295065B1
(en)
*
|
1998-02-20 |
2013-10-09 |
The University of Miami |
Modified heat shock protein-antigenic peptide complex
|
|
US20030236209A1
(en)
*
|
1998-03-18 |
2003-12-25 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
US7579160B2
(en)
|
1998-03-18 |
2009-08-25 |
Corixa Corporation |
Methods for the detection of cervical cancer
|
|
AU765050B2
(en)
*
|
1998-09-04 |
2003-09-04 |
Powderject Research Limited |
Immunodiagnostics using particle delivery methods
|
|
US20020142974A1
(en)
*
|
1998-09-11 |
2002-10-03 |
Leonard D. Kohn |
Immune activation by double-stranded polynucleotides
|
|
JP2003504074A
(ja)
|
1999-07-08 |
2003-02-04 |
ストレスゲン バイオテクノロジーズ コーポレイション |
インビトロでのＴｈ１様応答の誘導
|
|
GB9919733D0
(en)
*
|
1999-08-19 |
1999-10-20 |
Colaco Camilo |
Vaccines against intracellular pathogens
|
|
AUPQ233799A0
(en)
|
1999-08-19 |
1999-09-09 |
Minister For Agriculture, Minister For Land And Water Conservation For And On Behalf Of The State Of New South Wales |
Recombinant sub-unit vaccine
|
|
US7378096B2
(en)
*
|
1999-09-30 |
2008-05-27 |
Health Research, Inc. |
Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
|
|
US6984384B1
(en)
*
|
1999-09-30 |
2006-01-10 |
Health Research, Inc. |
Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
|
|
US8128922B2
(en)
|
1999-10-20 |
2012-03-06 |
Johns Hopkins University |
Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
|
|
AU1582801A
(en)
*
|
1999-11-05 |
2001-06-06 |
Board Of Regents Of The University Of Nebraska, The |
Methods and compositions for protection against bovine herpesvirus
|
|
US7030228B1
(en)
|
1999-11-15 |
2006-04-18 |
Miltenyi Biotec Gmbh |
Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
|
|
GB9930443D0
(en)
|
1999-12-22 |
2000-02-16 |
King S College London |
Novel use of heat shock proteins
|
|
US20010034042A1
(en)
*
|
2000-01-20 |
2001-10-25 |
Srivastava Pramod K. |
Complexes of peptide-binding fragments of heat shock proteins and their use as immunotherapeutic agents
|
|
US7297330B2
(en)
*
|
2000-02-04 |
2007-11-20 |
Thomas Jefferson University |
Low dose haptenized tumor cell and tumor cell extract immunotherapy
|
|
DE10019967A1
(de)
*
|
2000-04-20 |
2001-10-25 |
Fenning Biomed Gmbh Dr |
Antikörper gegen natives gp96, deren Herstellung und Verwendung
|
|
US7186515B1
(en)
|
2000-06-02 |
2007-03-06 |
University Of Connecticut Health Center |
Alpha(2) macroglobulin receptor as a heat shock protein receptor and uses thereof
|
|
EP1286693A4
(en)
|
2000-06-02 |
2005-07-13 |
Univ Connecticut Health Ct |
COMPLEXES OF ALPHA (2) MACROGLOBULIN AND ANTIGENIC MOLECULES FOR USE IN IMMUNOTHERAPY
|
|
US7179462B2
(en)
|
2000-06-02 |
2007-02-20 |
University Of Connecticut Health Center |
α (2) macroglobulin receptor as a heat shock protein receptor and uses thereof
|
|
IL153474A0
(en)
|
2000-06-26 |
2003-07-06 |
Stressgen Biotechnologies Corp |
Human papilloma virus treatment
|
|
WO2002012281A2
(en)
*
|
2000-08-03 |
2002-02-14 |
Johns Hopkins University |
Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
|
|
CN1107681C
(zh)
*
|
2000-08-11 |
2003-05-07 |
中国科学院微生物研究所 |
乙肝病毒抗原多肽与热休克蛋白的复合物及其应用
|
|
AU2001292674A1
(en)
*
|
2000-09-15 |
2002-04-29 |
University Of Connecticut Health Center |
Improved formulations using heat shock/stress protein-peptide complexes
|
|
US7132109B1
(en)
|
2000-10-20 |
2006-11-07 |
University Of Connecticut Health Center |
Using heat shock proteins to increase immune response
|
|
US20020172682A1
(en)
*
|
2000-10-20 |
2002-11-21 |
University Of Connecticut Health Center |
Using heat shock proteins to increase immune response
|
|
RU2295536C2
(ru)
*
|
2001-02-05 |
2007-03-20 |
Стрессджен Байотекнолоджиз Корп. |
Композиции на основе белка вируса гепатита в и стрессового белка и их применение
|
|
IL158819A0
(en)
*
|
2001-05-31 |
2004-05-12 |
Skyepharma Inc |
Encapsulation of nanosuspensions in liposomes and microspheres
|
|
US7071164B2
(en)
|
2001-08-16 |
2006-07-04 |
Kimberly-Clark Worldwide, Inc. |
Anti-cancer and wound healing compounds
|
|
US7186693B2
(en)
|
2001-08-16 |
2007-03-06 |
Kimberly - Clark Worldwide, Inc. |
Metalloproteinase inhibitors for wound healing
|
|
US6906036B2
(en)
|
2001-08-16 |
2005-06-14 |
Kimberly-Clark Worldwide, Inc. |
Anti-aging and wound healing compounds
|
|
US7094754B2
(en)
|
2001-08-16 |
2006-08-22 |
Kimberly-Clark Worldwide, Inc. |
Anti-aging and wound healing compounds
|
|
CA2457008A1
(en)
*
|
2001-08-20 |
2003-02-27 |
University Of Connecticut Health Center |
Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin useful for the treatment of cancer and infectious disease
|
|
US20030211971A1
(en)
*
|
2001-09-17 |
2003-11-13 |
Srivastava Pramod K. |
Compositions and methods for prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with compositions comprising unfractionated cellular proteins
|
|
WO2003029419A2
(en)
|
2001-10-01 |
2003-04-10 |
Duke University |
Three dimensional structure of crystalline grp94 binding domain, and its methods of use
|
|
US20030194409A1
(en)
*
|
2002-01-17 |
2003-10-16 |
Rothman James E. |
Conjugate heat shock protein-binding peptides
|
|
CA2477417A1
(en)
*
|
2002-02-28 |
2003-09-04 |
Antigenics Inc. |
Methods and products based on oligomerization of stress proteins
|
|
US6984389B2
(en)
|
2002-04-25 |
2006-01-10 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
JP2006501147A
(ja)
*
|
2002-04-25 |
2006-01-12 |
ユニバーシティー オブ コネティカット ヘルス センター |
非ワクチン治療法の治療効果を改善するための熱ショックタンパク質の使用
|
|
CN1665533A
(zh)
*
|
2002-05-02 |
2005-09-07 |
康涅狄格大学健康中心 |
热激蛋白用于增强抗体疗法功效的用途
|
|
DE60333500D1
(de)
*
|
2002-10-02 |
2010-09-02 |
Hoffmann La Roche |
Verfahren zur Identifizierung antigener Peptide
|
|
WO2004033657A2
(en)
*
|
2002-10-07 |
2004-04-22 |
Antigenics, Inc. |
Heat shock protein binding fragments of cd91, and uses thereof
|
|
CA2503457A1
(en)
*
|
2002-10-25 |
2004-05-06 |
University Of Connecticut Health Center |
Apparatus and method for immunotherapy of a cancer through controlled cell lysis
|
|
CA2509902A1
(en)
|
2002-12-13 |
2004-07-01 |
Aurelium Biopharma Inc. |
Nucleophosmin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
|
|
US7670604B2
(en)
|
2002-12-13 |
2010-03-02 |
Aurelium Biopharma, Inc. |
Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
|
|
WO2005062058A1
(en)
*
|
2002-12-13 |
2005-07-07 |
Aurelium Biopharma Inc. |
Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
|
|
US7148194B2
(en)
|
2002-12-30 |
2006-12-12 |
Kimberly-Clark Worldwide, Inc. |
Method to increase fibronectin
|
|
DE60323682D1
(de)
*
|
2003-01-03 |
2008-10-30 |
Aurelium Biopharma Inc |
Auf hsc70 gerichtete diagnostika und therapeutika für eine gegen mehrere arzneistoffe resistente tumorerkrankung
|
|
CA2512161A1
(en)
*
|
2003-01-28 |
2004-08-12 |
Shanghai Sunway Biotech Co., Ltd |
Hyperthermia oncolysis co-therapy
|
|
US7420037B2
(en)
|
2003-02-13 |
2008-09-02 |
Antigenics Inc. |
Heat shock protein-based vaccines and immunotherapies
|
|
RU2324493C2
(ru)
*
|
2003-02-20 |
2008-05-20 |
Юниверсити Оф Коннектикут Хелт Сентер |
Способ применения композиций, содержащих белки теплового шока или альфа-2-макроглобулин, для лечения рака и инфекционных болезней
|
|
US7638122B2
(en)
*
|
2003-03-07 |
2009-12-29 |
University Of South Florida |
Stat3 antagonists and their use as vaccines against cancer
|
|
US7358042B2
(en)
*
|
2003-03-14 |
2008-04-15 |
Aurelium Biopharma, Inc. |
Triosephosphate isomerase directed diagnostics and therapeutics for multidrug resistant neoplastic disease
|
|
US7309491B2
(en)
*
|
2003-04-11 |
2007-12-18 |
Antigenics Inc. |
Heat shock protein-based vaccines and immunotherapies
|
|
WO2004098526A2
(en)
*
|
2003-05-05 |
2004-11-18 |
Johns Hopkins University |
Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
|
|
WO2004101766A2
(en)
|
2003-05-12 |
2004-11-25 |
The Children's Hospital Of Philadelphia |
Grp94-based compositions and methods of use thereof
|
|
US20060029610A1
(en)
*
|
2003-05-12 |
2006-02-09 |
Yair Argon |
GRP94-based compositions and methods of use thereof
|
|
US7189700B2
(en)
|
2003-06-20 |
2007-03-13 |
Kimberly-Clark Worldwide, Inc. |
Anti-chrondrosarcoma compounds
|
|
US20080064048A1
(en)
*
|
2004-09-03 |
2008-03-13 |
Medical And Biological Laboratories, Co., Ltd. |
Methods for Selecting Proteins that are Readily Presented as Antigens on Dendritic Cells
|
|
EP1801202A4
(en)
*
|
2004-09-03 |
2008-02-06 |
Medical & Biol Lab Co Ltd |
METHOD FOR PRODUCING A DENDRITIC CELL WITH ACQUIRED CTL-INDUCING SKILL
|
|
WO2006073970A2
(en)
*
|
2005-01-06 |
2006-07-13 |
The Johns Hopkins University |
Rna interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by dna and transfected dendritic cell vaccines
|
|
CA2595726A1
(en)
*
|
2005-01-26 |
2006-08-03 |
The Johns Hopkins University |
Anti-cancer dna vaccine employing plasmids encoding mutant oncoprotein antigen and calreticulin
|
|
RU2287339C1
(ru)
*
|
2005-04-29 |
2006-11-20 |
Автономная некоммерческая организация "Институт Молекулярной Диагностики" (АНО ИнМоДи) |
Способ получения препарата, содержащего комплекс белков теплового шока 70,90,96, ассоциированных с антигенными пептидами
|
|
US20070167422A1
(en)
*
|
2006-01-18 |
2007-07-19 |
Yu Kwok S |
Pharmaceutical compositions comprising 17-allylamino-17-demethoxygeldanamycin
|
|
US20100330105A1
(en)
*
|
2006-08-22 |
2010-12-30 |
John Hopkins University |
Anticancer Combination Therapies
|
|
EP2091971A4
(en)
*
|
2006-11-13 |
2010-05-05 |
Functional Genetics Inc |
THERAPEUTIC VECTORING OF ESCORTE PROTEINS
|
|
US9085638B2
(en)
|
2007-03-07 |
2015-07-21 |
The Johns Hopkins University |
DNA vaccine enhancement with MHC class II activators
|
|
US20080260765A1
(en)
*
|
2007-03-15 |
2008-10-23 |
Johns Hopkins University |
HPV DNA Vaccines and Methods of Use Thereof
|
|
AU2009223838B2
(en)
|
2008-03-03 |
2012-07-26 |
The University Of Miami |
Allogeneic cancer cell-based immunotherapy
|
|
EP2274001A4
(en)
|
2008-03-20 |
2012-08-01 |
Univ Miami |
VACCINATION WITH HEAT SHOCK PROTEIN GP96 AND APPLICATION METHOD THEREFOR
|
|
US20090285861A1
(en)
*
|
2008-04-17 |
2009-11-19 |
Tzyy-Choou Wu |
Tumor cell-based cancer immunotherapeutic compositions and methods
|
|
US7932018B2
(en)
*
|
2008-05-06 |
2011-04-26 |
Az Electronic Materials Usa Corp. |
Antireflective coating composition
|
|
ES2963910T3
(es)
|
2008-06-26 |
2024-04-03 |
Zevra Denmark As |
Uso de Hsp70 como regulador de la actividad enzimática
|
|
GB0816242D0
(en)
*
|
2008-09-05 |
2008-10-15 |
Immunobiology Ltd |
Method of purifying protien complexes
|
|
US9186128B2
(en)
|
2008-10-01 |
2015-11-17 |
Covidien Lp |
Needle biopsy device
|
|
US11298113B2
(en)
|
2008-10-01 |
2022-04-12 |
Covidien Lp |
Device for needle biopsy with integrated needle protection
|
|
US9332973B2
(en)
|
2008-10-01 |
2016-05-10 |
Covidien Lp |
Needle biopsy device with exchangeable needle and integrated needle protection
|
|
US9782565B2
(en)
|
2008-10-01 |
2017-10-10 |
Covidien Lp |
Endoscopic ultrasound-guided biliary access system
|
|
US8968210B2
(en)
|
2008-10-01 |
2015-03-03 |
Covidien LLP |
Device for needle biopsy with integrated needle protection
|
|
AU2009316371B2
(en)
*
|
2008-11-21 |
2014-02-20 |
University Of Miami |
HIV/SIV vaccines for the generation of mucosal and systemic immunity
|
|
GB0910591D0
(en)
|
2009-06-19 |
2009-07-29 |
Immunobiology Ltd |
Method for the purification of protein complexes
|
|
PT2646044T
(pt)
|
2010-11-30 |
2019-11-12 |
Orphazyme As |
Métodos para aumentar a atividade intracelular de hsp70
|
|
FR3005649B1
(fr)
|
2013-05-15 |
2023-03-31 |
Urodelia |
Poudre d'hydroxyapatite et son procede de production, composition a base de cette poudre et son procede de preparation et kit comprenant cette poudre
|
|
SG10201912986PA
(en)
|
2014-05-28 |
2020-02-27 |
Agenus Inc |
Anti-gitr antibodies and methods of use thereof
|
|
HUE054957T2
(hu)
|
2014-09-15 |
2021-10-28 |
Orphazyme As |
Arimoklomol készítése
|
|
JP6744318B2
(ja)
|
2015-02-06 |
2020-08-26 |
ヒート バイオロジクス，インコーポレイテッド |
ワクチンおよび共刺激分子を共発現するベクター
|
|
CN107847572A
(zh)
|
2015-05-13 |
2018-03-27 |
艾吉纳斯公司 |
用于癌症治疗和预防的疫苗
|
|
US10144779B2
(en)
|
2015-05-29 |
2018-12-04 |
Agenus Inc. |
Anti-CTLA-4 antibodies and methods of use thereof
|
|
KR20220131277A
(ko)
|
2015-09-01 |
2022-09-27 |
아게누스 인코포레이티드 |
항-pd-1 항체 및 이를 이용하는 방법
|
|
IL299072A
(en)
|
2015-12-02 |
2023-02-01 |
Memorial Sloan Kettering Cancer Center |
Antibodies and methods of use thereof
|
|
EP3423088A4
(en)
*
|
2016-02-29 |
2019-11-13 |
The Curators Of The University Of Missouri |
IMMUNE-BASED CANCER THERAPY
|
|
US10898476B2
(en)
|
2016-04-13 |
2021-01-26 |
Orphazyme A/S |
Heat shock proteins and cholesterol homeostasis
|
|
RU2021117465A
(ru)
|
2016-04-29 |
2021-07-22 |
Орфазим А/С |
Аримокломол для лечения ассоциированных с глюкоцереброзидазой нарушений
|
|
KR20230091191A
(ko)
|
2016-05-27 |
2023-06-22 |
아게누스 인코포레이티드 |
항-tim-3 항체 및 이의 사용 방법
|
|
BR112019007369A2
(pt)
|
2016-10-11 |
2019-07-16 |
Agenus Inc |
anticorpos anti-lag-3 e métodos de uso dos mesmos
|
|
CA3040123A1
(en)
|
2016-10-11 |
2018-04-19 |
University Of Miami |
Vectors and vaccine cells for immunity against zika virus
|
|
MA50949B1
(fr)
|
2016-12-07 |
2023-12-29 |
Memorial Sloan Kettering Cancer Center |
Anticorps anti-ctla-4 et leurs procédés d'utilisation
|
|
CA3046082A1
(en)
|
2016-12-07 |
2018-06-14 |
Agenus Inc. |
Antibodies and methods of use thereof
|
|
AU2018207172B2
(en)
|
2017-01-13 |
2023-10-12 |
Mink Therapeutics, Inc. |
T cell receptors that bind to NY-ESO-1 and methods of use thereof
|
|
WO2018187260A1
(en)
|
2017-04-04 |
2018-10-11 |
Heat Biologics, Inc. |
Intratumoral vaccination
|
|
KR102629972B1
(ko)
|
2017-04-13 |
2024-01-29 |
아게누스 인코포레이티드 |
항-cd137 항체 및 이의 사용 방법
|
|
EP3618863B1
(en)
|
2017-05-01 |
2023-07-26 |
Agenus Inc. |
Anti-tigit antibodies and methods of use thereof
|
|
CA3073055A1
(en)
|
2017-09-04 |
2019-03-07 |
Agenus Inc. |
T cell receptors that bind to mixed lineage leukemia (mll)-specific phosphopeptides and methods of use thereof
|
|
FR3078887B1
(fr)
|
2018-03-14 |
2020-12-18 |
Urodelia |
Vaccins autologues contre le cancer
|
|
EP3784688A2
(en)
|
2018-04-26 |
2021-03-03 |
Agenus Inc. |
Heat shock protein-binding peptide compositions and methods of use thereof
|
|
US11680098B2
(en)
|
2019-08-30 |
2023-06-20 |
Agenus Inc. |
Antibodies that specifically bind human CD96
|
|
WO2022070052A1
(en)
*
|
2020-09-30 |
2022-04-07 |
Alma Bio Therapeutics |
Nucleic acid therapy for differential modulation of host microflora
|
|
IL303026A
(en)
|
2020-11-19 |
2023-07-01 |
Zevra Denmark As |
Processes for preparing arimoclomol citrate and intermediates thereof
|